View in EDS

Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy.

Saved in:
Bibliographic Details
Title: Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy.
Authors: Pacheco FS; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., da Rocha Mota RG; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Pinho Jannini de Sá YA; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA., Hogaboam CM; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA., Castro-Faria-Neto HC; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Carvalho VF; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; INOVA-IOC Network on Neuroimmunomodulation, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.
Source: Neuroimmunomodulation [Neuroimmunomodulation] 2026; Vol. 33 (1), pp. 213-224. Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article; Review
Journal Info: Publisher: S. Karger Medical and Scientific Publishers Country of Publication: Switzerland NLM ID: 9422763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0216 (Electronic) Linking ISSN: 10217401 NLM ISO Abbreviation: Neuroimmunomodulation Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1423-0216
DOI:10.1159/000551742